Source: Market Exclusive

Innovus Pharma: INNOVUS PHARMACEUTICALS (OTCMKTS:INNV) Files An 8-K Completion of Acquisition or Disposition of Assets

Read full article »

Innovus Pharma's Competitors | Innovus Pharma's News | Innovus Pharma's Financials

Followers on Owler

15

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

Bassam Damaj's photo - President & CEO of Innovus Pharma

President & CEO

Bassam Damaj

CEO Approval Rating

90/100

Innovus Pharma is a specialty pharmaceutical company that develops commercializes and licenses non-prescription medicine and consumer care products.